Format

Send to

Choose Destination
Clin Lung Cancer. 2000 Aug;2(1):74-7.

HER2/neu peptide-based vaccines, with GM-CSF as an adjuvant, in patients with advanced-stage HER2/neu-expressing cancers.

Author information

1
Division of Oncology, University of Washington, Seattle, Washington 98195, USA.
PMID:
14731345

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center